Although it has not been directly associated with susceptibility to any T2DM-related condition before, studies report a significant upregulation of the GYPA gene in the dorsal root ganglia of a mouse model of T2DM and the metabolic syndrome, and even type 1 diabetes with diabetic polyneuropathy [33, 34]. Here, GYPA is linked to diabetic neuropathy.